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Hepatic resection is the mainstay of curative treatment for hepatocellular
carcinoma (HCC).
1-4 However, debate is ongoing over the best way to select
candidates for surgery and how to decide the extent of hepatectomy. The decision
of whether or not to proceed with surgery depends mainly on the functional
reserve of the liver and the estimated risk of recurrence.
3,5-9 Although an ideal limit
of residual liver function to serve as a guideline in choosing a specific treatment
modality has not yet been established, preoperative measurement of liver function
is not difficult. Meanwhile, preoperative estimation of the risk of tumor
recurrence remains ambiguous. Therefore, it seems that the stratification of
preoperative risk factors for tumor recurrence is important not only in deciding
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Purpose: The risk of hepatocellular carcinoma (HCC) recurrence must be considered ahead of surgery. This study
was undertaken to identify pre-operative risk factors for early intrahepatic recurrence of HCC after curative resection
in a large-scale. Materials and Methods: We retrospectively reviewed the preoperative three-phase multi-detector
CT (MDCT) and laboratory data for 240 HCC patients who underwent curative resection; tumor size, number, gross
shape, capsule integrity, distinctiveness of tumor margin, portal vein thrombosis (PVT), alpha-fetoprotein level
(AFP), and protein induced by vitamin K absence-II (PIVKA-II) levels were assessed. Surgical pathology was
reviewed; tumor differentiation, capsule, necrosis, and micro-vessel invasion were recorded. Results: HCC recurred
in 61 patients within six months (early recurrence group), but not in 179 patients (control group). In univariate
analysis, large tumor size (p = 0.018), shape (p = 0.028), poor capsule integrity (p = 0.046), elevated AFP (p =
0.015), and PIVKA-II (p = 0.008) were significant preoperative risk factors. Among the pathologic features, PVT (p
= 0.023), Glisson’s capsule penetration (p = 0.033), microvascular invasion (p < 0.001), and poor differentiation (p =
0.001) showed statistical significance. In multivariate analysis, only the histopathologic parameters of microvascular
invasion and poor differentiation achieved statistical significance. Conclusion: Preoperative CT and laboratory
parameters showed limited value, while the presence of microscopic vascular tumor invasion and poorly
differentiated HCC correlated with higher risk of early recurrence after curative resection.
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INTRODUCTIONwhether or not to proceed with surgical resection, but also
in determining the optimal extent of hepatectomy in HCC
if surgery is to proceed. 
The purpose of this study was to identify risk factors that
could be detected preoperatively and postoperatively for
early recurrence of HCC after curative resection. For the
preoperative decision about hepatic resection, we analyzed
dynamic contrast-enhanced CT scans and tumor markers.
For post-operative treatment planning, we evaluated surgical
histopathologic features. 
Patient selection and review of medical history
We retrospectively reviewed the medical records of 414
consecutive patients who received curative resection for
HCC between January 2001 and February 2006 in one
tertiary medical center. Excluded from the study were
patients who either received liver transplantation or lobec-
tomy for palliative treatment (n = 22); patients whose
preoperative radiologic evaluation was not performed with
a three-phase dynamic enhanced multi-detector CT
(MDCT) scan within one month before surgery (n = 119);
patients whose tumor pathology was not that of pure
hepatocellular carcinoma, for example combined hepato-
cellular-cholangiocarcinoma (n = 23); and patients who
did not complete the six-month follow-up period (n = 10).
This process defined a study population of 240 patients,
and 181 men and 59 women between 31 and 76 years old
(mean ± standard deviation: 53.51 ± 9.04 years) were
included. One hundred and one patients had experience of
receiving transarterial chemoembolization prior to surgery,
while 139 patients had no experience of treatment prior to
surgery. The study population was later divided into early
recurrence and non-recurrence groups on the basis of six-
month follow-up results. 
CT image acquisition
Preoperative CT images were obtained by one of the follow-
ing commercially available MDCT; 4, 16, and 64 channel
MDCT scanners (Somatom Plus 40, Sensation 16, and
Sensation 64, Siemens Medical Systems, Erlangen,
Germany). Each patient was injected with 120 to 150 mL
of iobitridol (Xenetix 300; Guerbet, Aulnay-sous-Bois,
France) or iohexol (Omnipaque 300; Daiichi Pharmaceu-
tical, Tokyo, Japan) through an 18-gauge venous cannula
placed at the antecubital fossa for contrast injection, using
a mechanical injector with a fixed duration of 30 seconds.
After unenhanced images were obtained, dynamic three-
phase imaging was performed. The hepatic arterial, portal
venous, and delayed phases were scanned at 15 seconds,
40 seconds, and 180 seconds, respectively, after the aorta
reached 100 HU.
Preoperative CT finding analysis
The preoperative CT scan of each patient was reviewed by
a gastrointestinal radiologist with 8 years of experience in
hepatobiliary imaging. No clinical, laboratory, or pathology
information other than the presence of HCC was provided
during image analysis.
The tumor’s size (the longest diameter on the axial
plane), shape, capsule, and margin were evaluated. Tumor
shape was classified into four categories: nodular (round in
shape with size less than 5 cm), massive expanding (round
in shape with size equal to or greater than 5 cm), multino-
dular confluent, or infiltrative type. Tumor capsule integrity
was assessed on a five-point scale according to the percen-
tage of the tumor surface covered by the capsule (grade 1:
covering more than 75%, grade 2: covering 51 to 75%,
grade 3: covering 26 to 50%, grade 4: covering no more
than 25% or absent capsule, and grade 5: could not be
evaluated because of complete necrosis). The number of
identifiable tumor lesions that appeared to be hyperdense
on arterial phase and washed out on equilibrium phase
images was counted. Portal vein thrombosis was considered
to be present if a filling defect in the portal vein was observ-
ed at the portal phase of contrast enhancement.
Preoperative laboratory findings 
Serology studies of antigen and antibodies with or without
supplemental DNA studies revealed evidence of either
active or inactive states of underlying B viral hepatitis
(HBV) in 217 patients and C viral hepatitis (HCV) in 14
(one patient had both B and C viral hepatitis). Eight patients
did not show evidence of either HBV or HCV hepatitis.
Two patients had no records of serology tests for reasons
that could not be determined.
Alpha-fetoprotein level (AFP) and protein induced by
vitamin K absence-II (PIVKA-II) levels were recorded if
blood samples obtained within a month before surgery
were available.
Surgical pathology parameters
The surgical pathology report for each patient was reviewed;
and features including the presence or absence of portal
tumor thrombi, microscopic vessel invasion, tumor capsule
formation, and the success or failure of obtaining a tumor-
free surgical resection margin were recorded. The degree of
tumor differentiation was categorized according to the Ed-
mondson-Steiner classification as low-grade (Edmondson-
Steiner grade I and II) and high-grade tumor (Edmondson-
Steiner III and IV). Tumor differentiation could not be
assessed in 39 patients because of extensive necrosis of the
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tumor, and these patients were recorded as having missing
data. The extent of tumor necrosis reported by the pathologist
was recorded; we considered necrosis of 95% or more of
the entire tumor as nearly total necrosis and classified each
patient either in the group of nearly total necrosis (≥ 95%
necrosis of the whole tumor) or the low necrosis group (< 95%
necrosis of whole tumor). The physical relation of the
tumor with the Glisson’s capsule was categorized according
to a three-point scale (grade 1: tumor separated from the
Glisson’s capsule by normal liver parenchyma, grade 2:
direct contact of tumor with the Glisson’s capsule without
microscopic evidence of tumor penetration, and grade 3:
microscopic evidence of tumor penetrating the Glisson’s
capsule).
Follow-up after surgery
Patients were regularly followed up with dynamic CT
scans and serum tumor markers (AFP and/or PIVKA-II) at
3 to 6 months after surgery using additional liver MRI,
conventional angiography, and/or ultrasound if necessary.
Early recurrence was defined as tumor recurrence identified
within six months after surgery. 
Post-operative HCC recurrence was considered to be
present if either a focal lesion was identified measuring at
least two centimeters with arterial hypervascularization
which was demonstrated in at least two imaging modali-
ties, or a hypervascular nodule exceeding two centimeters
was noted in a single imaging study in the presence of over
400 ng/mL AFP.
10
In addition, any new nodule that had appeared during
the follow-up period, exceeding 2 cm in size, or a newly
appearing nodule showing contrast washout leading to
hypoattenuation in the equilibrium phase was considered
to be highly suspicious for HCC recurrence regardless of
size
11 and was confirmed with supplemental biopsy or
short-term follow-up CT or MRI.
Statistical analysis
The two-sample t-test, Chi-Square, and Fisher’s exact tests
were performed for univariate analysis, and a logistic
regression test was performed for multivariate analysis.
Statistical significance was accepted if the p value was less
than 0.05.
Among the 240 patients who were included in the study,
61 patients were proved to have tumor recurrence within
six months. The other 179 patients did not show evidence
of tumor recurrence during the same period. No statisti-
cally significant difference was found in the age (p = 0.226)
and gender (p = 0.085) profile between the early recurrence
and non-recurrence groups.
RESULTS
Fig. 1. A 56-year-old female with early recurrent HCC after segmentectomy. The AFP level in a blood sample obtained on the same day as the CT
scan was 1076.84 IU/mL. (A) Arterial phase of the preoperative CT obtained by a 4-slice MDCT. A mass measuring approximately 2.2 cm in diameter
which was later proven by surgery to be hepatocellular carcinoma is observed at the dome of the liver, presenting as a multinodular confulent
nodule (arrow). (B) Early washout (arrow) of contrast of this nodule is observed during the portal venous phase, an enhancement pattern consistent
with HCC. (C) The equilibrium phase of the preoperative CT. A linear enhancement structure (black arrow) was noted which was considered to be
the radiological capsule. The radiological capsule was assessed to cover less than 25% of the tumor circumference (capsule grade 4). The margin
of the nodule is poorly defined (white arrow). (D) Microscopic findings show high grade (Edmondson-Steiner grade III) hepatocellular carcinoma;
original magnification, ×200; hematoxylin-eosin (H & E). (E) Microscopic examination revealed frequent microvessel tumor invasion (white arrows),
original magnification, ×200; hematoxylin-eosin (H & E). (F) Marked increase of AFP level (10865.27 IU/mL) was observed at the fifth postoperative-
month blood test. He underwent a CT scan, which revealed an infiltrative hypervascular mass (white arrow). Another 1 cm sized hypervascular
nodule (black arrow) is noted, which increased further in size and measured to be 2.2 cm at a CT scan performed 4 months afterwards, and the
findings were highly suggestive of a HCC nodule. HCC, hepatocellular carcinoma; MDCT, multi-detector CT.
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According to univariate analysis for preoperative findings,
no significant difference in early recurrence was noted
according to the viral pathogen that caused the hepatitis (p =
0.151) or the history of receiving previous trans-arterial
chemoembolization (p = 0.616). However, the serum levels
of AFP (p = 0.015) and PIVKA-II (p = 0.008) were signi-
ficantly higher in the early recurrence group.
Univariate analysis of the preoperative CT features
showed that the shape of the tumor (p = 0.028) (Fig. 1),
size (p = 0.018), and capsule integrity (p = 0.046) were
related to a statistically significant increase in the risk for
early post-operative HCC recurrence. However, the number
of tumors (p = 0.118), the number of the liver segments
involved with the tumor (p = 0.526), the presence of portal
vein thrombosis (p = 0.216), and tumor margins (p =
0.564) did not show statistical significance (Table 1).
Univariate analysis showed that histopathology para-
meters such as the presence of portal vein tumor thrombi
(p = 0.023), microscopic vascular tumor invasion (p <
0.001), physical contact of the Glisson’s capsule by the
tumor with or without tumor penetration (p = 0.033), failure
to achieve tumor cell clear resection margins (p = 0.019),
and Edmondson-Steiner grade III and IV (p = 0.001)
indicated a higher risk of early post-operative HCC recur-
Table 1. Univariate Analysis of Preoperative CT and Laboratory Parameters in Patients with and without 
Early HCC Recurrence after Lobectomy
Risk factors
No early recurrence  Early recurrence 
pvalue
(n = 179) (n = 61)
Age (yrs, mean ± standard deviation)  53.96 ± 9.11 52.34 ± 8.50 0.226*
Sex (M / F) 130 / 49 51 / 10 0.085
�
Hepatitis 0.151
�
HBV 163 54
HCV 7 7
Non-B non-C 7 1
TACE history (present / absent) 77 / 102 24 / 37 0.616
�
AFP 791.25 ± 3022.51 7021.37 ± 32982.44 0.015*
PIVKA-II 287.23 ± 556.55 586.60 ± 756.89 0.008*
Size (cm) 4.32 ± 2.23 5.30 ± 2.90 0.018*
Number of tumors (single / multiple) 167 / 12 53 / 8 0.118
�
Number of involved segments 
80 / 99 2 5 / 36 0.526
�
(single / multiple segments involved) 
Shape of tumor 0.028
�
Nodular 74 13
Massive expanding 29 12
Multinodular confluent 63 27
Infiltrative 13 9
CT Portal vein thrombosis 
165/14 53/8 0.216
�
(absent / present)
Margin (well defined / poorly defined) 155 / 24 51 / 10 0.564
�
Capsule (present / absent or uncertain) 95 / 84 24 / 37 0.064
�
Capsule integrity (35 patients not
0.046
�
assessable due to necrosis)
> 75% 57 10
75 - 50% 38 13
50 - 25% 25 9
< 25% 32 21
HCC, hepatocellular carcinoma; HBV, B viral hepatitis; HCV, C viral hepatitis; TACE; AFP, alpha-fetoprotein level, PIVKA-II, protein induced by 
vitamin K absence-II. 
Statistical significance was accepted at pvalue lower than 0.05.
*Student t test.
�Chi-Square test.
�Fisher’s exact test.rence that was statistically significant. The presence or
absence of microscopic capsule formation (p = 0.132) and
the presence of nearly total necrosis (p = 0.212) did not
show statistical significance. 
Multivariate analysis with backward logistic regression
revealed a statistically significant increase of risk for early
post-operative tumor recurrence caused by the presence of
microscopic vascular invasion which was proved by histo-
logy (odds ratio = 2.557) and Edmondson-Steiner grade
III and IV (odds ratio = 2.814) (Table 3).
Intrahepatic tumor recurrence of HCC after treatment has
been explained by two different mechanisms, either secon-
dary metastasis or de novo development of a separate
primary HCC.
12 Chronic viral hepatitis and/or cirrhosis are
usually present in HCC patients, and these conditions are
risk factors which substantially contribute to the develop-
ment of HCC.
12-14 Therefore, even if a primary HCC is
cured, HCC recurrence by newly developed tumors is still
more or less inevitable. However, it is very difficult to
differentiate intrahepatic metastasis that originated from
the primary tumor from newly developed de novo HCC.
Imamura, et al.
15 suggested that early and late peak recur-
rence of HCC after resection could roughly represent intra-
hepatic metastasis and de novo HCC development, respec-
tively. Their suggestion is based on the analysis of the
different factors associated with early (non-anatomical
resection, presence of micro-vessel invasion, and serum
AFP > 32 ng/mL) and late (hepatitis activity, multiple
tumors, and gross tumor classification) recurrence.
Although the pathogenesis of recurrence is still under
investigation, early recurrence has stronger clinical
importance compared with late recurrence considering the
morbidity and mortality of surgery, cost-effectiveness, and
potential benefits of alternative treatments. To our
knowledge, however, large scale studies on the evaluation
of the radiologic, laboratory and surgical pathological
Early Post-Operative Recurrence of HCC
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Table 2. Univariate Analysis of Histopathological Parameters of Surgical Specimens in Patients with and 
without Early HCC Recurrence after Lobectomy
Risk factors
No early recurrence Early recurrence 
pvalue
(n = 179) (n = 61)
Portal vein tumor thrombi
173 / 6 54 / 7 0.023
�
(absent / present)
Glisson’s capsule 0.033
�
No contact with Glisson’s 54 11
Abutting capsule 121 45
Infiltration of capsule 4 5
Resection margin (negative / positive) 175 / 4 55 / 6 0.019
�
Microscopic vascular invasion 
132 / 47 28 / 33 < 0.001
�
(negative / positive)
Tumor capsule formation
119 / 60 34 / 27 0.132
�
(present / absent)
Necrosis (< 95% / ≥95%) 119 / 59 47 / 15 0.212
�
Edmondson grade (I and II / III and IV)
(39 patients were not assessable  84 / 59 19 / 39 0.001
�
due to extensive necrosis)
HCC, hepatocellular carcinoma. 
Statistical significance was accepted at pvalues lower than 0.05.
*Student t test.
�Chi-Square test.
�Fisher’s exact test.
DISCUSSION
Table 3. Multivariate Analysis of Laboratory, Preoperative CT, and Surgical Pathology Parameters in Patients 
with and without Early HCC Recurrence after Lobectomy
Coefficient S.E. Wald Significance Odds ratio
Microscopic vascular invasion 0.939 0.358 6.877 0.009 2.557
Edmondson grade (I and II / III and IV) 1.035 0.368 7.896 0.005 2.814
HCC, hepatocellular carcinoma.factors associated with early (within six months) recurrence
of HCC after curative resection remain limited. 
Large tumor size,
16 absence of tumor capsule, indistinct
margins,
17 and elevated serum levels of AFP
15,18 have been
reported as parameters which increase the risk of early
tumor recurrence. In the current study, univariate analysis
showed AFP (p = 0.015) and PIVKA-II (0.008) levels to
have statistical significance for predicting the risk of HCC
recurrence within six months. However, the role of tumor
markers seems to be limited, because statistical significance
was not reproduced in multivariate analysis.
In the present study, size, gross shape of tumor, and cap-
sule integrity were other radiological findings that showed
statistical significance, suggesting higher risk of early
tumor recurrence in univariate analysis. However, these
factors failed to maintain statistical significance in multi-
variate analysis. 
The presence of portal vein thrombosis identified in
preoperative CT scans did not have statistically significant
influence in the early HCC recurrence (p = 0.216). This
unexpected result could be due either to selection bias or the
small number of patients with positive portal vein throm-
bosis in our study. However, the observation that portal
vein thrombosis did not show statistical significance in
early HCC recurrence is consistent with a previous study.
17
Risk factors reported in previous articles on the basis of
surgical pathology are relatively consistent more with each
other. The presence of microscopic vascular invasion is a
factor repeatedly indicated as a potent risk factor.
15,16,18,19
Advanced histopathologic grade is also reported to have
statistical significance for HCC recurrence.
18,20 Similarly,
our study showed microscopic vascular invasion and
advanced histopathologic grades to have sustained statis-
tical significance, suggesting a higher risk of early recur-
rence in multivariate analysis. Other factors, including
positive portal vein tumor thrombi in the surgical specimen
and direct tumor contact with the Glisson’s capsule with or
without tumor penetration, were found to be parameters
with statistical significance only in univariate analysis. 
Previous history of trans-arterial chemoembolization and
the presence of nearly total necrosis of tumor with or
without previous treatment did not show statistical signi-
ficance in relation with the rate of early tumor recurrence.
In general practice, more advanced tumors tend to receive
more intensive preoperative adjuvant therapies; therefore,
we believe that selection bias with respect to the degree of
preoperative adjuvant therapies received does exist in our
study population. In spite of the statistically insignificant
results produced by the current study, we do not suggest
that preoperative adjuvant therapies are unnecessary. 
In conclusion, HCC patients with positive microscopic
vascular invasion of tumor and high Edmondson-Steiner
grades have a statistically significantly higher risk of early
postoperative recurrence. Most parameters of HCC that are
detectable preoperatively, including clinical and radiological
features, have limited significance in the prediction of
postoperative early recurrence. 
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